Table 3 Cardiopulmonary exercise parameters predictors of two-years mortality rate in patients in patients with selective drug therapy, ie, in patients with pulmonary artery hypertension and in patients with chronic thromboembolic pulmonary hypertension (n = 116)
From: Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension
| Â | Sensitivity | Specificity | odds ratio | significance |
|---|---|---|---|---|
| Â | Â | Â | [95% confidence interval] | Â |
VO2 (< 10.4 ml/min/kg) | 27% | 69% | 1.88 [1,58; 2,18] | p = 0.03 |
Ve/VCO2 (≥ 55) | 80% | 79% | 14.66 [12,70; 16,62] | p = 0.004 |
AaDO2 (≥ 55 mmHg) | 69% | 62% | 3.67 [3,11; 4,23] | p = 0.09 |
Ve/VCO2 slope (≥ 60) | 70% | 81% | 9.92 [6,68; 13,17] | p = 0.03 |
a-etCO2 (≥ 8 mmHg) | 62% | 69% | 3.63 [2,73; 4,53] | p = 0.02 |